journal article·2015-12-09

Multifunctional MRI/PET Nanobeacons Derived from the in Situ Self-Assembly of Translational Polymers and Clinical Cargo through Coalescent Intermolecular Forces

Charalambos Kaittanis, Travis M. Shaffer, Alexander Bolaender, Zachary Appelbaum, Jeremy Appelbaum, Gabriela Chiosis, Jan Grimm

Nano Letters· Volume 15· Issue 12
Publisher page

Abstract

Novel multifunctional platforms are needed for oncology in order to assist physicians during surgery and chemotherapy. In the present study, we show that polymeric nanobeacons, consisting of the glucose-based polymer dextran, can be used to guide surgery and improve drug delivery. For imaging, the nanobeacons stably retained the positron emitter 89-zirconium and the MRI contrast agent gadolinium, without the need of a chelator. In addition to using them for PET imaging, the (89)Zr-nanobeacons guided the surgical resection of sentinel lymph nodes, utilizing their inherent Cerenkov luminescence. Through weak electrostatic interactions, the nanoparticles carried combinations of chemotherapeutics for the simultaneous inhibition of oncogenic pathways, resulting in enhanced tumor regression. The nanobeacons also allowed monitoring of drug release via MRI, through the quenching of the gadolinium signal by the coloaded drug, making them a new multifunctional theranostic nanotechnology platform for the clinic.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Radiopharmaceutical Chemistry and Applications · Medical Imaging Techniques and Applications · Nanoparticle-Based Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Center for Advanced Medical Imaging Sciences, Department of Radiology, Massachusetts General Hospital, 55 Fruit Street, Boston, Massachusetts 02114, United States

Department of Chemistry, Hunter College and Graduate Center of the City University of New York, New York, New York 10065, United States

Funding

Alex’s Lemonade Stand Foundation · Starr Cancer Consortium · Commonwealth Foundation for Cancer Research · Center for Experimental Therapeutics, Memorial Sloan Kettering Cancer Center · NIH Office of the Director · Center of Molecular Imaging and Nanotechnology, Memorial Sloan Kettering Cancer Center · National Cancer Institute · Prostate Cancer Foundation · National Institute of Biomedical Imaging and Bioengineering · Division of Graduate Education

References (37)

Show source-provided references
1. 10.1038/onc.2011.60210.1038/onc.2011.602 ↗
2. 10.1038/nature0448010.1038/nature04480 ↗
3. 10.2217/fon.13.23110.2217/fon.13.231 ↗
4. 10.1016/j.molonc.2011.10.00510.1016/j.molonc.2011.10.005 ↗
5. 10.1038/nrc318010.1038/nrc3180 ↗
6. 10.1615/CritRevOncog.201401160110.1615/CritRevOncog.2014011601 ↗
7. 10.1148/radiol.1413152010.1148/radiol.14131520 ↗
8. 10.1016/j.addr.2011.06.01310.1016/j.addr.2011.06.013 ↗
9. 10.1093/annonc/mdh09710.1093/annonc/mdh097 ↗
10. 10.1093/jac/28.suppl_B.7310.1093/jac/28.suppl_B.73 ↗
11. 10.1126/scitranslmed.300365110.1126/scitranslmed.3003651 ↗
12. 10.1021/nl051922910.1021/nl0519229 ↗
13. 10.1021/mp100043h10.1021/mp100043h ↗
14. 10.1021/la903784310.1021/la9037843 ↗
15. 10.1021/ja505412p10.1021/ja505412p ↗
16. 10.1002/adma.20150220110.1002/adma.201502201 ↗
17. 10.1038/ncomms438410.1038/ncomms4384 ↗
18. 10.2217/nnm.14.20310.2217/nnm.14.203 ↗
19. 10.1148/radiol.1313085810.1148/radiol.13130858 ↗
20. 10.1016/j.biotechadv.2013.10.01110.1016/j.biotechadv.2013.10.011 ↗
21. 10.1007/s00259005057610.1007/s002590050576 ↗
22. 10.2967/jnumed.112.10434910.2967/jnumed.112.104349 ↗
23. 10.1002/wnan.4810.1002/wnan.48 ↗
24. 10.1038/nm.272110.1038/nm.2721 ↗
25. 10.1021/nl070700310.1021/nl0707003 ↗
26. 10.5173/ceju.2014.03.art1910.5173/ceju.2014.03.art19 ↗
27. 10.1038/ncomms409710.1038/ncomms4097 ↗
28. 10.1038/nm.247210.1038/nm.2472 ↗
29. 10.1038/nmat157110.1038/nmat1571 ↗
30. 10.1021/nl503522y10.1021/nl503522y ↗
31. 10.1016/B978-0-12-411638-2.00006-910.1016/B978-0-12-411638-2.00006-9 ↗
32. 10.1038/nm.332310.1038/nm.3323 ↗
33. 10.1097/MPA.0b013e318254f2d110.1097/MPA.0b013e318254f2d1 ↗
34. 10.1016/j.ccr.2011.04.00810.1016/j.ccr.2011.04.008 ↗
35. 10.1016/j.cell.2012.03.03110.1016/j.cell.2012.03.031 ↗
36. 10.1038/nchembio.67010.1038/nchembio.670 ↗
37. 10.1016/j.nucmedbio.2009.05.00710.1016/j.nucmedbio.2009.05.007 ↗